Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalenceRepublic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the needof antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination.
Avijgan
M
M
Department of Infectious and Tropical Diseases and Iranian Traditional Medicine Research Centre, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran. avijgan@yahoo.com
Habibian
R
R
Kheiri
S
S
D000293:Adolescent; D017677:Age Distribution; D000914:Antibodies, Viral / Q000097:blood*; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D016358:Contact Tracing; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D032521:Immunity, Herd; D017589:Immunization Programs / Q000379:methods; D007117:Immunization, Secondary; D007492:Iran / Q000453:epidemiology; D008297:Male; D009107:Mumps / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D009108:Mumps Vaccine / Q000276:immunology*; D009109:Mumps virus / Q000276:immunology*; D020380:Needs Assessment; D018579:Patient Selection; D016036:Seroepidemiologic Studies; D014611:Vaccination / Q000379:methods
D000914:Antibodies, Viral; D009108:Mumps Vaccine